NIT
TGTX icon

NumerixS Investment Technologies’s TG Therapeutics TGTX Stock Holding History

NumerixS Investment Technologies’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,300
Closed -$24K – 1235
2019
Q3 		$24K Buy
+4,300
New +$30K 0.01% 868
2019
Q1 		– Sell
-12,600
Closed -$50K – 1332
2018
Q4 		$50K Buy
+12,600
New +$62.6K 0.02% 770
2018
Q3 		– Sell
-9,500
Closed -$125K – 1367
2018
Q2 		$125K Sell
9,500
-100
-1% -$1.38K 0.03% 683
2018
Q1 		$135K Buy
9,600
+6,400
+200% +$81.8K 0.03% 554
2017
Q4 		$26K Buy
+3,200
New +$28K 0.01% 970
2017
Q3 		– Sell
-800
Closed -$8K – 1350
2017
Q2 		$8K Buy
+800
New +$8.95K ﹤0.01% 1068

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NumerixS Investment Technologies's TGTX Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of TG Therapeutics (TGTX) in Q4 2019, closing a stake of 4,300 shares — an estimated $24K sold.

NumerixS Investment Technologies first reported a position in TGTX in Q2 2017 and held it in 6 quarters. The position peaked at $135K in Q1 2018. 135 funds tracked by Wall St. Rank hold TGTX as of Q4 2019.

  • NumerixS Investment Technologies reported no remaining TG Therapeutics position as of Q4 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 4,300 TG Therapeutics shares in Q4 2019, an estimated $24K.
  • NumerixS Investment Technologies first reported a position in TG Therapeutics in Q2 2017 and held it in 6 quarters.
  • NumerixS Investment Technologies's TG Therapeutics position peaked at $135K in Q1 2018.
  • 135 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.